Wednesday, January 22, 2025

Kazem Kazempour

December 10, 2024

U.S. biotech CEOs convicted in securities fraud scheme

Nader Pourhassan and Kazem Kazempour engaged in a scheme to deceive investors about CytoDyn’s development of an investigational drug to inflate its stock price.

U.S. court room